• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911328300
Device Problem Occlusion Within Device (1423)
Patient Problem Reocclusion (1985)
Event Date 05/07/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
 
Event Description
Promus element (b)(6) clinical study.It was reported that in-stent restenosis occurred.In (b)(6) 2014, the patient presented due to unstable angina and was referred for cardiac catheterization.Subsequently, the index procedure was performed.The target lesion was located in the proximal left anterior descending (lad) artery with 70% stenosis and was 24mm long with a reference vessel diameter of 3.0mm.The target lesion was treated with direct placement of a 3.00x28mm promus element ¿ drug-eluting stent.Following post-dilatation, residual stenosis was 0%.After four days, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2018, the patient was noted with in-stent restenosis and hospitalized on the same day.After eight days, the 80% stenosis noted in the left main coronary artery (lmca) extending up to proximal lad which had previously placed study stent was treated with stent implantation.Post intervention, the residual stenosis was 0%.Three days after, the event was considered to be recovered/resolved and the patient was discharged on the same day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7637637
MDR Text Key112314037
Report Number2134265-2018-05826
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCN
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/26/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/01/2015
Device Model NumberH7493911328300
Device Catalogue Number39113-2830
Device Lot Number16384059
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/08/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/22/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
-
-